Skip to main content
Have a personal or library account? Click to login
An insight into statin use and its association with muscular side effects in clinical practice Cover

An insight into statin use and its association with muscular side effects in clinical practice

Romanian Journal of Internal Medicine
Volume 53 (2015): Issue 2 (June 2015)
By: ,  ,  ,  ,   and    
Open Access
|Oct 2015
References

References

  1. 1. BAIGENT C, KEECH A, KEARNEY PM, BLACKWELL L, BUCK G, POLLICINO C,.. Lancet 2005; 366:1267–1278.
    Open DOISearch in Google Scholar
  2. 2. SHEPHERD J, COBBE SM, FORD I, ISLES CG, LARIMER AR, MACFARLANE PW,.,. New Engl J Med 1995; 333:1301–7.
    Open DOISearch in Google Scholar
  3. 3. Scandinavian Simvastatin Survival Study Group.. Lancet 1994; 344:1383–9.
    Search in Google Scholar
  4. 4. KOLOVOU G.. Current Med Res and Opinion 2001; 17:34–7.
    Open DOISearch in Google Scholar
  5. 5. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group.. N Engl J Med 1998; 339(19):1349–1357.
    Open DOISearch in Google Scholar
  6. 6. BRADFORD RH, SHEAR CL, CHREMOS AN, DUJOVNE CA, FRANKLIN FA, GRILLO RB,.. Am J Cardiol 1994; 74(7):667–673.
    Open DOISearch in Google Scholar
  7. 7. STEINHAGEN-THIESSEN E.. Simvastatin Pravastatin European Study Group. Cardiology 1994; 85(3–4):244–254.
    Open DOISearch in Google Scholar
  8. 8. BERTOLINI S, BON GB, CAMPBELL LM, FARNIER M, LANGAN J, MAHLA G,. Atherosclerosis 1997; 130(1–2):191–197.
    Open DOISearch in Google Scholar
  9. 9. ARMITAGE J.. Lancet 2007; 370:1781–1790.
    Open DOISearch in Google Scholar
  10. 10. SILVA MA, SWANSON AC, GANDHI PJ, TATARONIS GR.. Clin Ther. 2006; 28:26-35.
    Open DOISearch in Google Scholar
  11. 11. SILVA M, MATTHEWS ML, JARVIS C, NOLAN NM, BELLIVEAU P, MALLOY M,. Clin Ther. 2007; 29(2):253-60.
    Open DOISearch in Google Scholar
  12. 12. THOMPSON PD, CLARKSON P, KARAS RH.. JAMA 2003; 289(13):1681–1690.
    Open DOISearch in Google Scholar
  13. 13. PASTERNAK RC, SMITH SC JR, BAIREY-MERZ CN, GRUNDY SM, CLEEMAN JI, LENFANT C.. J Am Coll Cardiol 2002; 40:567–572.
    Open DOISearch in Google Scholar
  14. 14. KASHANI A, PHILLIPS CO, FOODY JM, WANG Y, MANGALMURTI S, KO DT,. Circulation 2006; 114:2788–2797.
    Open DOISearch in Google Scholar
  15. 15. DE SAUVAGE NOLTING PR, BUIRMA RJ, HUTTEN BA, KASTELEIN JJ.[ExPRESS FH]). Am J Cardiol 2002; 90:181–184.
    Open DOISearch in Google Scholar
  16. 16. FRANC S, DEJAGER S, BRUCKERT E, CHAUVENET M, GIRAL P, TURPIN G.gs. Cardiovasc Drugs Ther 2003; 17:459–465.
    Open DOISearch in Google Scholar
  17. 17. GRAHAM DJ, STAFFA JA, SHATIN D, ANDRADE SE, SCHECH SD, LA GRENADE L,. JAMA 2004; 292(21): 2585–2590.
    Open DOISearch in Google Scholar
  18. 18. The SEARCH Collaborative Group.. N Engl J Med 2008; 359(8):789–799.
    Open DOISearch in Google Scholar
  19. 19. SINZINGER H, WOLFRAM R, PESKAR BA.. J Cardiovasc Pharmacol. 2002; 40(2):163-71.
    Open DOISearch in Google Scholar
  20. 20. FERNANDEZ G, SPATZ ES, JABLECKI C, PHILLIPS PS.. Cleve Clin J Med. 2011; 78(6):393-403.
    Open DOISearch in Google Scholar
  21. 21. NAKAI A, NISHIKOTA M, UCHIDA T, ICHIKAWA M, METSUYAMA K.. Chem Pharm Bull 997; 20:104–6.
    Open DOISearch in Google Scholar
  22. 22. ROWAN CG, BRUNELLI SM, MUNSON J, FLORY J, REESE PP, HENNESSY S,. Pharmacoepidemiol Drug Saf. 2012; 21(5):494-506.
    Open DOISearch in Google Scholar
  23. 23. BALLANTYNE CM, CORSINI A, DAVIDSON MH, HOLDAAS H, JACOBSON TA, LEITERSDORF E,. Arch Intern Med. 2003; 163(5):553-64.
    Open DOISearch in Google Scholar
  24. 24. DUGUÉ A, BAGHERI H, LAPEYRE-MESTRE M, TOURNAMILLE JF, SAILLER L, DEDIEU G,. Eur J Clin Pharmacol. 2004; 60(4):285-92.
    Open DOISearch in Google Scholar
  25. 25. BRUCKERT E, HAYEM G, DEJAGER S, YAU C, BÉGAUD B.. Cardiovasc Drugs Ther. 2005; 19(6):403-14.
    Open DOISearch in Google Scholar
  26. 26. MOSSHAMMER D, LORENZ G, MEZNARIC S, SCHWARZ J, MUCHE R, MÖRIKE K.. Fam Pract. 2009; 26(2):88-95.
    Open DOISearch in Google Scholar
  27. 27. HEDENMALM K, ALVAN G, OHAGEN P, DAHL ML.. Pharmacoepidemiol Drug Saf. 2010; 19(3):223-31.
    Open DOISearch in Google Scholar
  28. 28. PHILLIPS PS, HAAS RH, BANNYKH S, HATHAWAY S, GRAY NL, KIMURA BJ,. Ann Intern Med. 2002; 137(7):581-5.
    Open DOISearch in Google Scholar
  29. 29. CORSINI A.. Cardiovasc Drugs Ther. 2005; 19(6):379-81.
    Open DOISearch in Google Scholar
  30. 30. GAIST D, RODRÍGUEZ LA, HUERTA C, HALLAS J, SINDRUP SH.. Epidemiology 2001; 12(5):565-9.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.1515/rjim-2015-0021 | Journal eISSN: 2501-062X (formerly 1220-4749) | Journal ISSN: 1220-4749
Journal RSS Feed
Language: English, Romanian
Page range: 153 - 160
Published on: Oct 14, 2015
Published by: N.G. Lupu Internal Medicine Foundation
In partnership with: Paradigm Publishing Services
Keywords:
statins,
myopathy,
muscular side-effects
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Internal medicine, other,
Cardiology,
Gastroenterology,
Rheumatology

© 2015 Andreea Farcas, Camelia Bucsa, D. Leucuta, Cristina Mogosan, M. Bojita, D. Dumitrascu, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 53 (2015): Issue 2 (June 2015)
Previous article
Next article